Fairvalue-Calculator Fairvalue-Calculator
EN DE

Auxly Cannabis Group (XLY) Fair Value & Analysis

Healthcare · CA · Market cap C$229M

PriceC$0.1800
Fair ValueC$0.4100
Upside+127.8%
Quality95/100
Evidence: High Range C$0.2300 – C$0.5200

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Auxly Cannabis Group (XLY) currently trades at C$0.1800, while our model-based Fair Value estimate is C$0.4100 — implying the stock looks roughly 127.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is Auxly Cannabis Group (XLY) undervalued?
As of Jun 26, 2026, our model estimates a fair value of C$0.4100 versus a price of C$0.1800 — about +128% (undervalued). Model-based estimate, not financial advice.
What is the fair value of XLY?
Our 21-model fair value for Auxly Cannabis Group is C$0.4100 (as of Jun 26, 2026), built from audited fundamentals. The current price is C$0.1800.
What is the quality score of XLY?
Auxly Cannabis Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.